LAP-BAND Observational Cohort
Recruitment status was Active, not recruiting
To prospectively observe the association of the LAP-BAND procedure on quality of life, anthropometric, metabolic and biochemical parameters in morbidly obese patients when performed by experienced US surgeons. The study will also include a complete economic analysis of the LAP-BAND procedure and follow-up costs Hypothesis: Measurements defining quality of life and the severity of obesity and obesity related comorbidities improve significantly over baseline with the LAP-BAND System treatment at 6 and 12 months post surgery when performed by an experienced surgeon.
Epworth Sleepiness Scale
Iron and Bone Turnover
IW-QOL Lite HRQoL
Device: LAP-BAND System
|Study Design:||Observational Model: Defined Population
Time Perspective: Longitudinal
|Official Title:||Health Outcome Study of LAP-BAND Adjustable Gastric Banding System|
|Study Start Date:||June 2005|
|Estimated Study Completion Date:||December 2006|
Study Type: Observational cohort. Single arm (non-comparative), non-randomized, multi-site surgical case series.
Objective: To prospectively observe the association of the LAP-BAND System device on measurements of quality of life, anthropometric, metabolic and biochemical parameters in morbidly obese patients when performed by experienced U.S. surgeons. Cost effectiveness analysis will also be done.
Numbers: This study will enroll 240 patients total from six U.S. bariatric surgical practices
Duration: Individual subject participation will be approximately 15 months. Data will be collected at a baseline less than three months prior to surgery or before starting a Very Low Calorie Diet (VLCD), then at 6 and 12 months post surgery. The total duration, including enrollment, of the observational period for the cohort is expected to be 21 months. Subjects have the option to consent for future contact by investigators for a period of 10 years following their surgery.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00283972
|Study Chair:||Daniel Deykin, MD||Massachusetts Veterans Epidemiology Research adn Information Center|
|Principal Investigator:||Louis Fiore, MD||Department of Veterans Affairs|